Tooth Margaret sold $28K of TRUP

Tooth Margaret (CEO) sold 978 shares of TRUPANION, INC. (TRUP) at $29.05 on 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Tooth Margaret
Published Aug 13, 2026, 10:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 13, 2026, 10:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRUP
Neutral
medium confidence
Mentioned
$TRUP
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRUPNeutralLow
01

Why it matters

The newest disclosed fact is the CEO’s open-market sale details (shares, price, total value) executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 structure limits actionable inference.

03

What to watch

10b5-1 plans are pre-scheduled; without additional context (e.g., option exercises, other insider buys), the signal-to-noise is low.

Relevance 2/10Novelty 3/10Timing: Filed after-hours on 2026-08-13, covering a sale dated 2026-08-11.

Background

The article is an SEC Form 4 insider transaction disclosure for TRUPANION, INC.

Company-level read

Ticker impact

$TRUPNeutralMedium confidence
Context

TRUP insider CEO Margaret Tooth sold 978 shares at $29.05 on 2026-08-11 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

Minimal, as this is company-specific insider selling with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The sale could be purely liquidity-driven (taxes, diversification) and should not be treated as a bearish fundamental signal.

Key entities

  • TRUPANION, INC.

    Company whose CEO filed the Form 4 insider sale disclosure.

  • Margaret Tooth

    CEO and director who sold 978 shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRUPMedAI 8/10

Why is Trupanion (TRUP) stock soaring today

Trupanion (TRUP) shares rose 6.5% after reporting Q3 2026 revenue of $405.6M, up 10.5% YoY, and EPS of $0.21, both exceeding estimates. The company also reported strong cash flow and share repurchases. The stock has been volatile, with a 52-week low reached after a Q4 2025 EPS miss.

$TRUPHighAI 8/10

Trupanion Q3 Earnings Call Highlights

Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.

$TRUPMed

Trupanion Inc (TRUP) Q3 2026 Earnings Call Highlights: Record Adjusted Operating Income

Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.

$TRUPHigh

Trupanion Reports Third Quarter 2026 Results

TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart

$TRUPMedAI 8/10

Property & Casualty Insurance Stocks Q2 Results: Benchmarking Trupanion (NASDAQ:TRUP)

Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.